Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Please see full Prescribing Information for AREXVY ... those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2023, and GSK’s Q2 Results for 2024.

GSK spun off Haleon to form a new consumer healthcare entity ... In 2023, the company reported full-year revenues of $14.7bn, up 4% year-on-year, operating profit of $2.6bn, up 9.4% and ...

Coolers full of vaccine strapped to their motorbikes ... mostly, as she is unable to form words. Her mother, Nazma, had been outside with the baby when we arrived; in these rooms nine families ...

Bond yields are falling, as City investors anticipate tax rises in Rachel Reeves’s first budget. Campari shares tumble ...

GSK will pay $80 million upfront and as much as $570 million to gain full development and commercialization rights to ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...